$MDLN · Medline Inc. SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for Medline Inc. ($MDLN) from November 4, 2026 through November 4, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$MDLN 10-Q — Medline Inc.
Strong top-line growth is being offset by margin compression and higher taxes, signaling profitability pressure despite robust demand.
$MDLN 8-K — Medline Inc.
A guidance raise plus a $1B buyback amid double-digit organic growth signals strong momentum despite a fire-driven profit decline.